Features

As psychedelic drugs are poised to join the mainstream, what is the role of the prescriber?

Dogs, ants, and other organisms that sniff out cancer could help train an AI to do the same.

An interview with MIT biologist David Sun Kong—on science, activism, and how biotechnology can empower ordinary people.

10% of women suffer from this painful condition, which often goes undiagnosed for years. This has to change.

Elephant skin walls, robotic flower houses, “Baubotanik” buildings, a treehouse on Mars, and the Mother Nature future of urban design.

Alto Neuroscience wants to use EEG brain biomarkers to better match the right treatment to a person’s needs.

Music and psychedelics go hand-in-hand. Could both have a healing effect?

London-based startup Wavepaths is creating a new kind of music technology explicitly designed for psychedelic therapy.

Insect-based foods, fuels, fertilizers, and antimicrobials will be a part of our future, like it or not.

Microbiome research has huge implications for the very sick. But can startups get healthy people in on the action?

An experimental drug that addresses anhedonia could increase the brain’s capacity to experience pleasure and herald a new era of precision medicine in psychiatry.

Demand from body builders, neonatal intensive care units, and Big Pharma fuels synbio substitutions for the goodness of breast milk.

A growing wave of novel substances for performance enhancement or just getting high hits the streets weekly.

Psilocybin, MDMA, and ketamine can lead to a new sense of self and a release from rigid rules for people with anorexia, bulimia, and binge-eating disorder.

Corporate America is embracing mindfulness more than ever as the pandemic rages. But what do they mean by “mindfulness,” and does it work?